2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with calcimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hebert, JS; Hruza, LL; Jacobs, SC; Morrison, AR; Packer, L; Pentland, AP | 1 |
Bai, CX; Furukawa, T; Kurokawa, J; Namekata, I; Shigenobu, K; Tanaka, H | 1 |
2 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and calcimycin
Article | Year |
---|---|
Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition.
Topics: Arachidonic Acids; Bradykinin; Calcimycin; Cells, Cultured; Chromans; Dinoprostone; Humans; Keratinocytes; Kinetics; Phospholipases; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Tritium; Vitamin E | 1992 |
Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes.
Topics: Action Potentials; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Chromans; Delayed Rectifier Potassium Channels; Electric Stimulation; Guinea Pigs; Heart Ventricles; Ion Transport; Ionophores; Membrane Potentials; Myocytes, Cardiac; Nisoldipine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Potassium; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |